Acquisition of Routine Vaccines and Medicines for INHP

This tender pertains to the acquisition of routine vaccines and medicines for the National Institute of Public Health (INHP) as part of the Côte d'Ivoire Health, Nutrition, and Early Childhood Development Program. The procurement method employed is a Request for Bids (RFB), with the reference number CI-CEP-PSNDPE-442261-GO-RFB. The specific scope of the contract includes the procurement of the Pneumococcal vaccine (Pneumo 23, 1 dose) under Lot 8. The project is financed by the International Development Association (IDA) with loan reference IDA-73830. The contract duration is set for six months, with the notification of award issued on July 23, 2025. The awarded bidder for this contract is GROUPEMENT CATALYSE BEAUTÉ SANTÉ/DEPOPHARMA, located at 25 BP 1084 ABIDJAN 25, Côte d'Ivoire. The contact number for the awarded bidder is 27 22 44 80 80, and they can be reached via email at catalysebeautesante.cbs@yahoo.com. The bid price at opening was not disclosed, but the evaluated bid price is XOF 150,000,000, with the signed contract price totaling XOF 300,000,000. This procurement is crucial for enhancing public health services in Côte d'Ivoire.

This is a supplies contract in the health and medical services, water and sanitation and finance and banking sectors, with a focus on Vaccines and Nutrition. Located in Cote d'Ivoire, Africa, this opportunity is open to firms and consortiums, with an estimated budget of USD 300.0 million.

Published through WB - World Bank, a multilateral development bank that follows standardized international procurement guidelines. Projects funded by multilateral institutions are generally open to international bidders from eligible member countries for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.